TY - JOUR
T1 - Imaging of brain tumors
T2 - MR spectroscopy and metabolic imaging
AU - Horská, Alena
AU - Barker, Peter B.
N1 - Funding Information:
Supported in part by National Institutes of Health grant P41 RR015241
PY - 2010/8
Y1 - 2010/8
N2 - The utility of magnetic resonance spectroscopy (MRS) in diagnosis and evaluation of treatment response to human brain tumors has been widely documented. The role of MRS in tumor classification, tumors versus nonneoplastic lesions, prediction of survival, treatment planning, monitoring of therapy, and post-therapy evaluation is discussed. This article delineates the need for standardization and further study in order for MRS to become widely used as a routine clinical tool.
AB - The utility of magnetic resonance spectroscopy (MRS) in diagnosis and evaluation of treatment response to human brain tumors has been widely documented. The role of MRS in tumor classification, tumors versus nonneoplastic lesions, prediction of survival, treatment planning, monitoring of therapy, and post-therapy evaluation is discussed. This article delineates the need for standardization and further study in order for MRS to become widely used as a routine clinical tool.
KW - Brain tumors
KW - Magnetic resonance spectroscopy
KW - Metabolites
KW - Spectroscopic imaging
UR - http://www.scopus.com/inward/record.url?scp=77955573546&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955573546&partnerID=8YFLogxK
U2 - 10.1016/j.nic.2010.04.003
DO - 10.1016/j.nic.2010.04.003
M3 - Review article
C2 - 20708548
AN - SCOPUS:77955573546
SN - 1052-5149
VL - 20
SP - 293
EP - 310
JO - Neuroimaging Clinics of North America
JF - Neuroimaging Clinics of North America
IS - 3
ER -